Honoring Legacies of Dr. Paul Swerdlow & Sickle Cell Caregivers A Memorial Program to Support Patients and Student Scholars.
The FSCDR & Phoenicia BioScience and are sponsoring a Student Scholar and My Sickle Cell Health Passport Program and to carry on traditions of Sickle Cell Specialists who touched many lives.
My Sickle Cell Health Passport will be pilot-tested by teen and young adult patients as an aid to help learn about essential care and to facilitate their own care in medical facilities new to them, or where the complexities of sickle cell disease are not well known.
The Program will also fund Summer Scholarships for high school and college students to learn about sickle cell disease, the important roles provided by different medical caregivers, and promote RESPECT for all persons living with sickle cell disease. The Program will provide a stipend for shadowing in Sickle Cell Treatment programs, using the Passport as a guide.
To Support Students Scholars and this Program: Donations can be made to the FSCDR, designated for the RESPECT PROGRAM
Founding Donors:Carolyn & Julie Swerdlow, Yutaka Niihara MD, Susan & Cynthia Perrine, Phoenicia BioScience
To learn more, donate, or apply: [email protected]; [email protected], [email protected]
Dr. Swerdlow had lifelong dedication to his patients with sickle cell disease.
He obtained his MD from the Harvard-MIT Program in Health Science and was Professor of Medicine & Pediatrics, Hematology Oncology, Wayne State University, and previously Director, Comprehensive Sickle Cell Center, Virginia Commonwealth University. He was on the Medical Staff of Karmanos Cancer Institute, Children’s Hospital of Michigan, and 3 other hospitals.
He directed research, was Investigator on >20 clinical trials, and served on the Advisory Council for Sickle Cell Disease to the NIH/NHLBI, and as Reviewer for NIH & the FDA Office of Orphan Product Development.
He compassionately cared for 3 generations of patients and devoted his clinical teaching of medical students, residents, and Hematology Fellows to improve patients’ lives.
Dr. Wally Smith, a Leader and Authority on pain, credits Dr Swerdlow for requesting his expertise for the VCA Sickle Cell Program and introducing him to the field.
Dr. Swerdlow always referred to his patients as “our women, our men, and our children”
Originally from Palestine, Dr. Ballas attended college and American University of Beirut School of Medicine in Lebanon on United Nations scholarships. Devoted to patients living with sickle cell disease from his first lecture, he obtained US Medical Boards in 3 specialties, authored > 700 papers, was a lifelong Advocate & Ambassador for patients, always analyzing and translating medical needs and therapies. His daughter relates his dedication was so constant, “Sickle Cell Disease was …. like a family member. He knew every patient’s life story & wanted every patient to be respected and heard… with compassion.” Dr. Ballas encouraged many hematologists in their career development.
After obtaining his MD and D. Trop Med & Hyg. at UCSF School of Medicine & Univ. of Liverpool, he cared for underserved patients in California, Hawaii, Guam, Virginia, and Saudi Arabia as Chief of Internal Medicine for Aramco, where he discovered patients with sickle cell disease & high HbF, living healthy, into older age in an era and region high-risk for deadly infections and early mortality. The HbS gene conferred a survival advantage vs severe malaria. He often spoke fondly about the dignity of his patients when teaching young physicians.
With Oxford Professors Sir David Weatherall, Bill Wood, & Doug Higgs, they discovered genetic changes causing HbH and high HbF, now a basis for therapies. In other efforts, he founded the country’s first Cardiac Care Unit, brought Pnemovax to Middle East patients, and with M. Pembrey produced a Bronze award-winning documentary film on sickle cell disease, distributing it to UK and US medical schools.
Creation of the Student Scholar Program was recommended by Aidan and Isabelle Faller, who as college students, shadowed Drs. Kevin Kuo and Richard Ward at Toronto General Hospital, the largest hemoglobinopathy program in North America.
Emily Vilk NP & Sarah Singer NP, Drs. Nura El-Haj, Stefanie Lowas, & Naheed Usmani
Cloret C, Patient Representative
Dr. Cathy Rosenfield, Associate Professor of Pediatrics, Tufts Univ. School of Medicine
Dr. Philippa Sprinz, Emerita Associate Professor of Pediatrics, Warren Alpert Brown Univ. School of Medicine
Please share your experience with your Provider
or
Click on the links below for Patients or for Caregivers